# Kuehn Law Encourages Investors of Intellia Therapeutics, Inc. to Contact Law Firm

--News Direct--

Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Intellia Therapeutics, Inc. (NASDAQ: NTLA) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.

If you own NTLA please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The consultation and case are free with no obligation to you. Kuehn Law pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

Why Your Participation Matters:

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.â„¢

For additional information, please visit Shareholder Derivative Litigation - Kuehn Law.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contact DetailsJustin Kuehn

+1 833-672-0814

justin@kuehn.law

Company Websitehttps://www.kuehn.law/

View source version on newsdirect.com: https://newsdirect.com/news/kuehn-law-encourages-investors-of-intellia-therapeutics-inc-to-contact-law-firm-739759807 

---

[Original/Source Press Release](https://newsdirect.com/news/kuehn-law-encourages-investors-of-intellia-therapeutics-inc-to-contact-law-firm-739759807)
                    

[Newsramp.com TLDR](https://newsramp.com/curated-news/kuehn-law-investigates-potential-breach-of-fiduciary-duties-at-intellia-therapeutics-inc/680781fd101bcd213fe2993289c4f54b) 


Pickup - [citybuzz.co](https://citybuzz.co/2024/04/02/kuehn-law-firm-investigates-potential-breach-of-fiduciary-duties-at-intellia-therapeutics)
 



[Reddit Post](https://www.reddit.com/r/Business_NewsRamp/comments/1bu0n0s/kuehn_law_investigates_potential_breach_of/) 



![Blockchain Registration](https://cdn.newsramp.app/news-direct/qrcode/244/2/ideaDl0a.webp)